Processing and presentation of variant surface glycoprotein molecules to T cells in African trypanosomiasis.
Th1 cell responses to the variant surface glycoprotein (VSG) of African trypanosomes play a critical role in controlling infection through the production of IFN-gamma, but the role of APCs in the induction and regulation of T cell-mediated protection is poorly understood. In this study, we have investigated the Ag presentation capabilities of dendritic cells (DCs) and macrophages during early trypanosome infection in relatively resistant responder and susceptible nonresponder mouse strains. Splenic DCs appeared to be the primary cell responsible for activating naive VSG-specific Th cell responses in resistant responder animals through the coordinated up-regulation of costimulatory molecules, secretion of IL-12, and presentation of VSG peptides to T cells in vivo. Splenic DC depletion and the down-regulation of costimulatory markers on splenic macrophages were observed in susceptible animals and may be associated with the inability of these animals to elicit a significant VSG-specific T cell response. In contrast to splenic APCs, peritoneal macrophages secreted NO, failed to activate naive Th cells in vitro, and presented relatively low levels of VSG peptides to T cells in vivo. Thus, VSG-specific Th1 cell responses may be determined by tissue- and cell-specific differences in Ag presentation. Additionally, all APCs from resistant and susceptible strains displayed a reduced ability to process and present newly encountered exogenous Ag, including new VSG molecules, during high parasitemia. Thus, initial uptake of VSG (or other trypanosome factors) may interfere with Ag presentation and have dramatic consequences for subsequent T cell responses to other proteins.
Dagenais
Taylor R
TR
Department of Bacteriology, University of Wisconsin-Madison, Madison, WI 53706, USA.
Freeman
Bailey E
BE
Demick
Karen P
KP
Paulnock
Donna M
DM
Mansfield
John M
JM
D000818:Animals; D017951:Antigen Presentation / Q000235:genetics / Q000276:immunology*; D002462:Cell Membrane / Q000276:immunology / Q000378:metabolism / Q000469:parasitology; D016207:Cytokines / Q000378:metabolism; D003713:Dendritic Cells / Q000276:immunology / Q000469:parasitology / Q000473:pathology; D005260:Female; D020022:Genetic Predisposition to Disease; D000949:Histocompatibility Antigens Class II / Q000096:biosynthesis / Q000276:immunology / Q000378:metabolism; D016130:Immunophenotyping; D017737:Macrophages, Peritoneal / Q000276:immunology / Q000378:metabolism / Q000469:parasitology; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008822:Mice, Transgenic; D016176:T-Lymphocyte Subsets / Q000276:immunology* / Q000378:metabolism / Q000469:parasitology*; D018417:Th1 Cells / Q000276:immunology / Q000378:metabolism / Q000469:parasitology; D016833:Trypanosoma brucei rhodesiense / Q000276:immunology*; D014353:Trypanosomiasis, African / Q000276:immunology* / Q000469:parasitology / Q000473:pathology; D014643:Variant Surface Glycoproteins, Trypanosoma / Q000096:biosynthesis / Q000378:metabolism* / Q000502:physiology
D016207:Cytokines; D000949:Histocompatibility Antigens Class II; D014643:Variant Surface Glycoproteins, Trypanosoma
J Leukoc Biol. 1998 Apr;63(4):429-39
9544572
Cell. 2002 Apr 5;109(1):5-8
11955440
J Immunol. 1990 May 15;144(10):4022-9
1970594
Exp Parasitol. 1970 Dec;28(3):521-34
4993889
Eur J Immunol. 1992 Oct;22(10):2741-4
1396977
J Exp Med. 2006 Jun 12;203(6):1427-33
16754719
Immunol Cell Biol. 1996 Dec;74(6):555-63
8989594
J Immunol. 1993 Apr 1;150(7):2910-9
8454863
Eur J Immunol. 1989 May;19(5):829-35
2525474
Parasitology. 1975 Dec;71(3):393-417
645
J Immunol. 1988 Jan 1;140(1):283-8
3121739
Infect Immun. 2000 Feb;68(2):848-60
10639455
J Immunol. 2003 Aug 15;171(4):1950-60
12902498
Parasite Immunol. 2000 Jul;22(7):361-70
10886720
Trends Genet. 1992 Dec;8(12):452-7
1492370
Ann Soc Belg Med Trop. 1992;72 Suppl 1:27-38
1417167
Infect Immun. 1999 Jun;67(6):3128-32
10338530
Infect Immun. 2003 Jun;71(6):3337-42
12761116
Int Immunol. 2003 Aug;15(8):993-1006
12882837
Exp Parasitol. 1992 Nov;75(3):353-60
1426137
Nature. 1993 Apr 15;362(6421):603-9
8464512
Mol Biochem Parasitol. 1992 Mar;51(1):119-32
1373472
Cytokine. 2000 Jul;12(7):1024-34
10880248
J Immunol. 1984 Sep;133(3):1564-9
6747297
Infect Immun. 1995 Apr;63(4):1563-6
7890423
Infect Immun. 2006 Aug;74(8):4530-7
16861639
Infect Immun. 1998 Feb;66(2):451-61
9453595
Am J Trop Med Hyg. 1982 Nov;31(6):1098-102
6183984
Toxicol In Vitro. 2001 Aug-Oct;15(4-5):319-25
11566556
J Immunol. 2007 Jul 1;179(1):548-56
17579076
Nature. 1987 Jan 1-7;325(6099):84-6
2432433
J Leukoc Biol. 2001 May;69(5):685-90
11358974
J Immunol. 1979 Mar;122(3):818-24
376707
Parasite Immunol. 1999 Feb;21(2):57-71
10101716
Parasitol Today. 1994 Jul;10(7):267-70
15275443
Parasite Immunol. 2005 Oct-Nov;27(10-11):361-71
16179030
Cell Immunol. 1980 Sep 1;54(2):414-24
6448095
J Immunol. 1983 Jan;130(1):405-11
6847889
J Immunol. 2005 Aug 15;175(4):2501-9
16081822
J Immunol. 1997 Jan 1;158(1):308-14
8977204
Res Immunol. 1993 Jun;144(5):370-6
8278660
J Immunol. 2003 Aug 1;171(3):1466-72
12874239
J Immunol. 1990 May 15;144(10):4011-21
1692071
Science. 1994 Feb 11;263(5148):814-7
8303299
J Immunol. 1993 Nov 15;151(10):5492-503
8228241
J Mol Evol. 1996 May;42(5):500-11
8662002
J Immunol. 1998 Dec 15;161(12):6775-83
9862708
J Cell Biol. 1997 May 5;137(3):715-27
9151676
J Infect Dis. 2001 Mar 15;183(6):988-91
11237819
J Parasitol. 1995 Dec;81(6):876-81
8544057
Cell Immunol. 1984 Aug;87(1):85-91
6378394
Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):4022-7
9108098
Infect Immun. 1981 Jul;33(1):149-55
6114926
Biochem Biophys Res Commun. 1994 Dec 15;205(2):984-91
7528505
J Immunol. 2000 Mar 1;164(5):2379-85
10679073
Parasite Immunol. 1990 May;12(3):233-46
2143570
Infect Immun. 2009 Jan;77(1):141-51
18936180
J Immunol. 2002 Oct 1;169(7):3652-60
12244157